Asesoría digestiva para solucionar tu caso de raíz: 👉 https://eliteatleta.com/servicios/nutricion-digestivaCapítulos 0:00 La fruta que te hincha y por qué te pasa2:09 Qué frutas evitar y cuáles toleras mejor4:44 Zumos y smoothies6:07 Cómo recuperar la fruta paso a paso7:18 ¿La intolerancia a la fructosa se cura?---BIBLIOGRAFÍAFrieling, T., Kuhlbusch-Zicklam, R., Kalde, S., Heise, J., Hülsdonk, A., & Kreysel, C. (2011). Fructose Malabsorption: How Much Fructose Can a Healthy Subject Tolerate? Digestion, 84(4), 269-272. https://doi.org/10.1159/000329570Gibson, P. R., Newnham, E., Barrett, J. S., Shepherd, S. J., & Muir, J. G. (2007). Review article: fructose malabsorption and the bigger picture. Alimentary Pharmacology & Therapeutics, 25(4), 349-363. https://doi.org/10.1111/j.1365-2036.2006.03186.xLatulippe, M. E., & Skoog, S. M. (2011). Fructose Malabsorption and Intolerance: Effects of Fructose with and without Simultaneous Glucose Ingestion. Critical Reviews in Food Science and Nutrition, 51(7), 583-592. https://doi.org/10.1080/10408398.2011.566646Nucera, G., Gabrielli, M., Lupascu, A., Lauritano, E. C., Santoliquido, A., Cremonini, F., Cammarota, G., Tondi, P., Pola, P., Gasbarrini, G., & Gasbarrini, A. (2005). Abnormal breath tests to lactose, fructose and sorbitol in irritable bowel syndrome may be explained by small intestinal bacterial overgrowth. Alimentary Pharmacology & Therapeutics, 21(11), 1391-1395. https://doi.org/10.1111/j.1365-2036.2005.02493.xWilder-Smith, C. H., Materna, A., & Olesen, S. S. (2023). Blueberries Improve Abdominal Symptoms, Well-Being and Functioning in Patients with Functional Gastrointestinal Disorders. Nutrients, 15(10), 2396. https://doi.org/10.3390/nu15102396---Instagram: https://www.instagram.com/eliteatletaWeb: https://www.eliteatleta.com

Asesorías 1a1 Digestivo - https://eliteatleta.com/servicios/nutricion-digestiva

Capítulos: 0:00 — El gran error2:00 — El SIBO no es uno4:07 — Cómo funciona el test4:58 — SIBO 17:50 — SIBO 210:39 — Secreto13:08 — El largo plazo

BIBLIOGRAFÍA

Chander Roland, B., Mullin, G. E., Passi, M., Zheng, X., Salem, A., Yolken, R., & Pasricha, P. J. (2017). A prospective evaluation of ileocecal valve dysfunction and intestinal motility derangements in small intestinal bacterial overgrowth. Digestive Diseases and Sciences, 62(12), 3525-3535. https://doi.org/10.1007/s10620-017-4828-z

Gatta, L., & Scarpignato, C. (2017). Systematic review with meta-analysis: Rifaximin is effective and safe for the treatment of small intestine bacterial overgrowth. Alimentary Pharmacology & Therapeutics, 45(5), 604-616. https://doi.org/10.1111/apt.13928

Lauritano, E. C., Gabrielli, M., Scarpellini, E., Lupascu, A., Novi, M., Sottili, S., Vitale, G., Cesario, V., Serricchio, M., Cammarota, G., Gasbarrini, G., & Gasbarrini, A. (2008). Small intestinal bacterial overgrowth recurrence after antibiotic therapy. The American Journal of Gastroenterology, 103(8), 2031-2035. https://doi.org/10.1111/j.1572-0241.2008.02030.x

Low, K., Hwang, L., Hua, J., Zhu, A., Morales, W., & Pimentel, M. (2010). A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test. Journal of Clinical Gastroenterology, 44(8), 547-550. https://doi.org/10.1097/MCG.0b013e3181c64c90

Pimentel, M., Chow, E. J., & Lin, H. C. (2003). Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome: A double-blind, randomized, placebo-controlled study. The American Journal of Gastroenterology, 98(2), 412-419. https://doi.org/10.1111/j.1572-0241.2003.07234.x

Rezaie, A., Buresi, M., Lembo, A., Lin, H., McCallum, R., Rao, S., Schmulson, M., Valdovinos, M., Zakko, S., & Pimentel, M. (2017). Hydrogen and methane-based breath testing in gastrointestinal disorders: The North American Consensus. The American Journal of Gastroenterology, 112(5), 775-784. https://doi.org/10.1038/ajg.2017.46

Polifenoles y microbiota intestinal: los compuestos vegetales que esquivan la digestión, llegan intactos al colon y alimentan selectivamente a las bacterias buenas. Si quieres una salud intestinal de hierro, esto es lo que la ciencia más reciente está midiendo de verdad.CAPÍTULOS00:00 — Intro01:03 — Punto 1: el ecosistema intestinal01:55 — Punto 203:02 — Punto 3: Bifidobacterium, alimentación cruzada y producción de butirato04:50 — Punto 4: evidencia clínica en cifras06:35 — Punto 507:46 — Recompensas---BIBLIOGRAFÍARecharla, N., Geesala, R., & Shi, X.-Z. (2023). Gut microbial metabolite butyrate and its therapeutic role in inflammatory bowel disease: A literature review. Nutrients, 15(10), 2275. https://doi.org/10.3390/nu15102275Toderescu, C. D., Parveen, M., Trifunschi, S., Oancea, A., Ciubuc, G. C., Cresneac, I. G., Munteanu, M. F., Ciopanoiu, I., Boru, C., Pogurschi, E. N., Ionite, C., Stefanache, A., & Lungu, I. I. (2026). Dietary polyphenols as modulators of Bifidobacterium in the human gut microbiota. Nutrients, 18(5), 782. https://doi.org/10.3390/nu18050782Yan, H., & Ajuwon, K. M. (2017). Butyrate modifies intestinal barrier function in IPEC-J2 cells through a selective upregulation of tight junction proteins and activation of the Akt signaling pathway. PLOS ONE, 12(6), e0179586. https://doi.org/10.1371/journal.pone.0179586---Instagram: https://www.instagram.com/eliteatletaWeb: https://www.eliteatleta.com